Status:

COMPLETED

Safety and Efficacy Study in Acute Ischaemic Stroke

Lead Sponsor:

Vernalis (R&D) Ltd

Conditions:

Stroke

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

A Phase II study to evaluate the safety and efficacy of five dose levels of study drug in acute ischaemic stroke

Detailed Description

An open label, dose escalation study where patients with acute ischaemic stroke will receive a single intravenous dose of study drug. There will be five dose levels with groups of 10 patients in each....

Eligibility Criteria

Inclusion

  • Summary of
  • Onset of new neurological signs of stroke within 3 to 9 hours of the time to initiation of treatment
  • Aged 18 and above
  • Provide consent
  • Cerebral CT scan to show findings of early ischaemic changes consistent with the clinical diagnosis and an ASPECT score of between 5 and 10 inclusive.
  • NIHSS score greater than 5 or less than or equal to 20.
  • Summary of

Exclusion

  • Coma
  • Stroke with unknown time of onset
  • Minor stroke symptoms and sings (\<6 points on the NIHSS) which are rapidly improving by the time of randomisation.
  • Major stroke symptoms and signs (\>20 on the NIHSS)
  • History of stroke in previous 6 weeks
  • History of brain tumours
  • CT scan results in an ASPECT score of \<5
  • Haemorrhagic risk
  • Abnormal laboratory values
  • Positive urine pregnancy test, lactation or parturition within previous 30 days.
  • Weight \>135 kg
  • Uncontrolled hypertension.
  • Raised blood glucose
  • History of or current serious illness
  • Participation in another clinical trial within 4 weeks of drug administration
  • \-

Key Trial Info

Start Date :

August 1 2005

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 1 2009

Estimated Enrollment :

49 Patients enrolled

Trial Details

Trial ID

NCT00144014

Start Date

August 1 2005

End Date

March 1 2009

Last Update

June 3 2016

Active Locations (28)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 7 (28 locations)

1

Stroke Centre, Mayo Clinic

Scottsdale, Arizona, United States, 85054

2

UCLA Stroke Network

Los Angeles, California, United States, 90024

3

Neurology Medical Group of Diablo Valley

Walnut Creek, California, United States, 94598

4

Bethesda Memorial Hospital

Boynton Beach, Florida, United States, 33435